Citigroup
TLSI icon

Citigroup’s TriSalus Life Sciences TLSI Stock Holding History

Citigroup’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.29K Buy
2,073
+1,385
+201% +$6.78K ﹤0.01% 5112
2025
Q4 		$4.8K Buy
688
+329
+92% +$1.84K ﹤0.01% 5255
2025
Q3 		$1.67K Sell
359
-5,068
-93% -$23.7K ﹤0.01% 5525
2025
Q2 		$29.6K Buy
5,427
+4,469
+466% +$24K ﹤0.01% 4977
2025
Q1 		$5.29K Buy
+958
New +$5.1K ﹤0.01% 5266

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Citigroup's TLSI Position: Q1 2026 in Review

Citigroup increased its TriSalus Life Sciences (TLSI) stake by 201% in Q1 2026, buying an estimated $6.78K and bringing the position to 2,073 shares worth $8.29K. The position accounts for ﹤0.01% of the portfolio, ranked #5112.

Citigroup first reported a position in TLSI in Q1 2025 and has held it in 5 quarters since. The position peaked at $29.6K in Q2 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Citigroup held 2,073 shares of TriSalus Life Sciences worth $8.29K as of Q1 2026.
  • Citigroup bought 1,385 TriSalus Life Sciences shares in Q1 2026, an estimated $6.78K.
  • TriSalus Life Sciences made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5112 holding.
  • Citigroup first reported a position in TriSalus Life Sciences in Q1 2025 and has held it in 5 quarters since.
  • Citigroup's TriSalus Life Sciences position peaked at $29.6K in Q2 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.